686 related articles for article (PubMed ID: 8643970)
1. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
Hainsworth JD; Greco FA
Semin Oncol; 1995 Dec; 22(6 Suppl 15):45-9. PubMed ID: 8643970
[TBL] [Abstract][Full Text] [Related]
2. European experience with ifosfamide in non-small cell lung cancer.
Drings P
Semin Oncol; 1989 Feb; 16(1 Suppl 3):22-30. PubMed ID: 2539645
[TBL] [Abstract][Full Text] [Related]
3. A phase II study of ifosfamide, cisplatin, etoposide in patients with advanced non-small cell lung cancer: a preliminary report.
Shepherd FA; Goss PE; Latreille J; Stewart D; Logan D; Evans WK; Maroun J; Warner E
Semin Oncol; 1990 Apr; 17(2 Suppl 4):19-23. PubMed ID: 2159185
[TBL] [Abstract][Full Text] [Related]
4. Phase II trial evaluating continuous infusion of etoposide, cisplatin, and hexamethylmelamine in extensive-disease small cell carcinoma of the lung.
Remick SC; Neville AJ; Willson JK
Cancer Treat Rep; 1987 Jun; 71(6):575-80. PubMed ID: 3034422
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy with carboplatin/cisplatin/ifosfamide/etoposide in ovarian cancer.
Lund B; Hansen OP; Hansen HH; Hansen M
Semin Oncol; 1992 Feb; 19(1 Suppl 1):26-9. PubMed ID: 1411618
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of cisplatin, ifosfamide, and etoposide combination for advanced non-small cell lung cancer: final report.
Shirinian M; Lee JS; Dhingra HH; Greenberg J; Hong WK
Semin Oncol; 1992 Dec; 19(6 Suppl 12):58-63. PubMed ID: 1336623
[TBL] [Abstract][Full Text] [Related]
7. Concurrent cisplatin and etoposide with radiotherapy in locally advanced non-small cell lung cancer.
Friess GG; Baikadi M; Harvey WH
Cancer Treat Rep; 1987; 71(7-8):681-4. PubMed ID: 3038313
[TBL] [Abstract][Full Text] [Related]
8. Ambulatory combination chemotherapy with oral etoposide and cisplatin for advanced non small cell lung carcinoma patients. A phase II study.
Focan C; Le Hung S; Frere MH; Schallier D
Anticancer Res; 1986; 6(5):977-81. PubMed ID: 3026238
[TBL] [Abstract][Full Text] [Related]
9. Treatment of advanced non-small cell lung cancer (NSCLC): the "Umbria" cooperative study.
Crinó L; Darwish S; Corgna E; Meacci ML; Di Costanzo F; Buzzi F; Fornari G; Santi F; Ballatori E; Luccioli L
Semin Oncol; 1988 Dec; 15(6 Suppl 7):52-5. PubMed ID: 2851180
[TBL] [Abstract][Full Text] [Related]
10. [Adriamycin, cisplatin, and etoposide combination chemotherapy for small cell lung cancer].
Irino S; Fujita J; Yamaji Y; Futami H; Hashimoto Y; Bungo M; Iuchi Y; Kamei M; Nakamura H; Hata Y
Gan To Kagaku Ryoho; 1989 Jun; 16(6):2263-7. PubMed ID: 2544150
[TBL] [Abstract][Full Text] [Related]
11. The expanding role of cisplatin in the treatment of non-small-cell lung cancer.
Bunn PA
Semin Oncol; 1989 Aug; 16(4 Suppl 6):10-21. PubMed ID: 2548280
[TBL] [Abstract][Full Text] [Related]
12. [Pilot phase II study of hybrid chemotherapy of CAV-PVP in small cell lung cancer (SCLC)].
Ueoka H; Ohnoshi T; Hiraki S; Kawahara S; Numata T; Nishii K; Yonei T; Yamashita H; Moritaka T; Kiura K
Gan To Kagaku Ryoho; 1989 Jun; 16(6):2251-5. PubMed ID: 2544149
[TBL] [Abstract][Full Text] [Related]
13. [A combination phase II study of adriamycin, CDDP and etoposide in small cell lung cancer].
Honda R; Fujita A; Inoue Y; Asakawa M; Tagaki S; Ohshima S; Suzuki A
Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 1):375-9. PubMed ID: 2155585
[TBL] [Abstract][Full Text] [Related]
14. Concurrent chemotherapy and thoracic irradiation in non-small cell lung cancer.
Bonomi P; Reddy S; Faber LP
Hematol Oncol Clin North Am; 1990 Dec; 4(6):1143-58. PubMed ID: 1962781
[TBL] [Abstract][Full Text] [Related]
15. [A combination chemotherapy of cisplatin and etoposide in small cell lung cancer].
Honda R; Nishiwaki Y; Hino M; Hayashibe A; Yano H; Kitaya T; Matsuyama T
Gan To Kagaku Ryoho; 1986 Oct; 13(10):2965-9. PubMed ID: 3021067
[TBL] [Abstract][Full Text] [Related]
16. Carboplatin in non-small cell lung cancer: review of the Eastern Cooperative Oncology Group trial and comparison with other carboplatin trials.
Bonomi P
Semin Oncol; 1991 Feb; 18(1 Suppl 2):2-7. PubMed ID: 1846979
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of vindesine, cisplatin, and hexamethylmelamine (VCH) in small cell carcinoma of the lung.
Daugaard G; Hansen HH; Rørth M
Cancer Treat Rep; 1984 Sep; 68(9):1179-81. PubMed ID: 6090016
[TBL] [Abstract][Full Text] [Related]
18. Combination chemotherapy with ifosfamide, mitomycin, and cisplatin in advanced non-small cell lung cancer.
Girón CG; Ordónez A; Jalón JI; Barón MG
Cancer Treat Rep; 1987 Sep; 71(9):851-3. PubMed ID: 3040245
[TBL] [Abstract][Full Text] [Related]
19. Combination chemotherapy for small cell carcinoma of the lung: continuous versus alternating non-cross-resistant combinations.
Aisner J; Whitacre M; Van Echo DA; Wiernik PH
Cancer Treat Rep; 1982 Feb; 66(2):221-30. PubMed ID: 6275987
[TBL] [Abstract][Full Text] [Related]
20. [Pilot phase II trial of high-dose etoposide combined with cisplatin in the treatment of refractory lung cancer].
Fujita J; Morikawa N; Yamaji Y; Kubo A; Takigawa K; Yamagishi Y; Fujita T; Shiotani T; Takahara J; Irino S
Gan To Kagaku Ryoho; 1992 Jun; 19(6):849-54. PubMed ID: 1318697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
